DIURETIC AND NATRIURETIC RESPONSES IN RATS TREATED WITH ENKEPHALINASE INHIBITORS

被引:31
作者
BRALET, J
MOSSIAT, C
LECOMTE, JM
CHARPENTIER, S
GROS, C
SCHWARTZ, JC
机构
[1] INSERM,U109,UNITE NEUROBIOL & PHARMACOL,2TER RUE ALESIA,F-75014 PARIS,FRANCE
[2] FAC PHARM DIJON,PHARMACODYNAM LAB,F-21000 DIJON,FRANCE
[3] LAB BIOPROJET,F-75003 PARIS,FRANCE
关键词
Acetorphan; ANF (atrial natriuretic factor); Spontaneously hypertensive rats (SHR); Thiorphan; Volume loading;
D O I
10.1016/0014-2999(90)90401-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rat atrial natriuretic factor (125I-rANF, 99-128) is hydrolysed by pure enkephalinase (EC 3.4.24.11) in vitro at a rate similar to that of 125I-hANF. Trichloroacetic precipitated radioactivity was significantly elevated in the kidneys of rats pretreated with acetorphan, an enkephalinase inhibitor, and receiving 125I-rANF, indicating that the exogenous hormone was protected against degradation. A single oral administration of acetorphan elicited diuretic and natriuretic effects in conscious normotensive rats and natriuretic effects in spontaneously hypertensive rats, effects which were not accompanied by significant changes in kaliuresis. The diuretic and natriuretic effects were still observed in conscious normotensive rats after three days of repeated administration of the drug. In conscious or anesthetized rats in which volume expansion was elicited by hydroelectrolytic loads, the initial rate of urinary elimination of water and sodium was nearly doubled by treatment with enkephalinase inhibitors. This effect was prevented by coadministration of an ANF antiserum, which suggests that the effect was mediated by endogenous ANF. These various observations suggest that enkephalinase inhibitors protect endogenous ANF from degradation and thereby enhance the typical renal effects of the hormone. © 1990.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 33 条
[11]   INACTIVATION OF ATRIAL-NATRIURETIC-FACTOR IN MICE INVIVO - CRUCIAL ROLE OF ENKEPHALINASE (EC 3.4.24.11) [J].
GROS, C ;
SOUQUE, A ;
SCHWARTZ, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 179 (1-2) :45-56
[12]   PROTECTION OF ATRIAL NATRIURETIC FACTOR AGAINST DEGRADATION - DIURETIC AND NATRIURETIC RESPONSES AFTER INVIVO INHIBITION OF ENKEPHALINASE (EC 3.4.24.11) BY ACETORPHAN [J].
GROS, C ;
SOUQUE, A ;
SCHWARTZ, JC ;
DUCHIER, J ;
COURNOT, A ;
BAUMER, P ;
LECOMTE, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7580-7584
[13]   ATRIAL NATRIURETIC FACTOR, URINARY CATECHOL COMPOUNDS AND ELECTROLYTE EXCRETION IN RATS DURING NORMAL HYDRATION AND ISOTONIC VOLUME EXPANSION - INFLUENCE OF DOPAMINE RECEPTOR BLOCKADE [J].
HANSELL, P ;
ANDEN, NE ;
GRABOWSKAANDEN, M ;
ULFENDAHL, HR .
ACTA PHYSIOLOGICA SCANDINAVICA, 1988, 134 (03) :421-428
[14]   VASCULAR RECEPTOR-BINDING ACTIVITIES AND CYCLIC-GMP RESPONSES BY SYNTHETIC HUMAN AND RAT ATRIAL NATRIURETIC PEPTIDES (ANP) AND RECEPTOR DOWN-REGULATION BY ANP [J].
HIRATA, Y ;
TOMITA, M ;
TAKADA, S ;
YOSHIMI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (02) :538-546
[15]   THE RENAL RESPONSE TO ACUTE HYPERVOLEMIA IS CAUSED BY ATRIAL NATRIURETIC PEPTIDES [J].
HIRTH, C ;
STASCH, JP ;
JOHN, A ;
KAZDA, S ;
MORICH, F ;
NEUSER, D ;
WOHLFEIL, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (02) :268-275
[16]   PURIFICATION AND COMPLETE AMINO-ACID-SEQUENCE OF ALPHA-HUMAN ATRIAL NATRIURETIC POLYPEPTIDE (ALPHA-HANP) [J].
KANGAWA, K ;
MATSUO, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (01) :131-139
[17]   ATRIAL NATRIURETIC FACTOR - A CIRCULATING HORMONE STIMULATED BY VOLUME LOADING [J].
LANG, RE ;
THOLKEN, H ;
GANTEN, D ;
LUFT, FC ;
RUSKOAHO, H ;
UNGER, T .
NATURE, 1985, 314 (6008) :264-266
[18]  
LARAGH JH, 1985, NEW ENGL J MED, V313, P1330
[19]  
LECOMTE JM, 1986, J PHARMACOL EXP THER, V237, P937
[20]   ENKEPHALIN DIPEPTIDYL CARBOXYPEPTIDASE (ENKEPHALINASE) ACTIVITY - SELECTIVE RADIOASSAY, PROPERTIES, AND REGIONAL DISTRIBUTION IN HUMAN-BRAIN [J].
LLORENS, C ;
MALFROY, B ;
SCHWARTZ, JC ;
GACEL, G ;
ROQUES, BP ;
ROY, J ;
MORGAT, JL ;
JAVOYAGID, F ;
AGID, Y .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (04) :1081-1089